• Coupang, Inc. has released its second-quarter 2026 results, showing revenue of US$8,856 million versus US$8,524 million a year earlier, but moving from net income of US$32 million to a net loss of US$570 million.
• Over the first half of 2026, Coupang’s revenue edged up to US$17,360 million while net income shifted from US$139 million profit to US$836 million loss, sharply changing the company’s recent profitability profile.
• We’ll now examine how this swing to a significant net loss, despite ongoing revenue growth, could reshape Coupang’s investment narrative.

AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Coupang Investment Narrative Recap

To own Coupang today, you need to believe its logistics heavy e commerce model can eventually convert steady revenue gains into consistent profits, despite setbacks along the way. The sharp swing to a US$570 million Q2 net loss, and US$836 million loss in the first half of 2026, brings profitability back to the forefront as the key near term catalyst and risk. This result materially heightens concerns about cost discipline and the path to sustainable earnings.

Among recent announcements, the expansion of Coupang’s share repurchase authorization to US$2,000 million, with roughly US$635 million already spent, stands out in light of these losses. Buybacks can support per share metrics and signal confidence, but paired with a rapid move into negative earnings they also raise fair questions about capital allocation and financial flexibility at a time when higher operating and investment costs are weighing on results.

Yet, against this backdrop, the real risk investors should be aware of is how rising costs and sustained losses in newer markets could...

Coupang's narrative projects $47.4 billion revenue and $1.3 billion earnings by 2029. This requires 10.5% yearly revenue growth and an earnings increase of about $1.5 billion from -$165.0 million today.

Uncover how Coupang's forecasts yield a $25.83 fair value, a 54% upside to its current price.

Exploring Other Perspectives

The most cautious analysts were already assuming only about 9.9 percent annual revenue growth and US$968 million earnings by 2029, so this sharp 2026 loss may push you to reassess whether that more pessimistic path now looks more realistic than the consensus view.

Explore 7 other fair value estimates on Coupang - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Coupang research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Coupang research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Coupang's overall financial health at a glance.

Contemplating Other Strategies?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Outshine the giants: these 17 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.